Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof
Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
11/2010
11/23/2010US7838595 high purity; storage stability; electrophilically activated polymer derivatives with aldehyde functionality for conjugating to biologically active molecules; drug-polymer conjugate;
11/23/2010US7837995 Anticancer agents; low dosage; side effect reduction
11/23/2010US7837993 Methods and compositions for regeneration of aged skeletal muscle tissues
11/17/2010EP2251425A1 Process for producing protein A-like protein with use of Brevibacillus genus bacterium
11/17/2010EP2249661A2 Products and methods to prevent infection
11/17/2010CN101885776A N-end chemical modification of ciliary neurotrophic factor (CNTF) and preparation method thereof
11/16/2010US7834160 preparing a buffer containing a protein (ferritin), zinc ion, and ammonia, adding hydrogen peroxide to the buffer so that the concentration of hydrogen peroxide is 60 mM or greater and 150 mM or less; source of nanoparticles of zinc oxide
11/16/2010US7834154 Angiogenesis inhibition
11/16/2010US7834150 Isolated cold-and-menthol-sensitive receptor (CMR1)
11/16/2010US7833967 polypeptide having antimicrobial activity, having an amino acid sequence selected from e.g. Arg Arg Arg Pro Pro Arg Leu Pro Arg Pro Phe Pro; Phe Arg Pro Pro Pro Arg Pro Arg Pro Leu Pro Val; detergents, animal feed
11/16/2010CA2237159C Glycosaminoglycan-antithrombin iii/heparin cofactor ii conjugates
11/13/2010CA2666008A1 A method for water purification
11/11/2010WO2010019725A9 Node polypeptides for nanostructure assembly
11/11/2010WO2007133835A8 Ras mutation and compositions and methods related thereto
11/11/2010US20100285982 Immunogenic peptides of influenza virus
11/11/2010US20100285131 Fgf21 mutants and uses thereof
11/11/2010US20100282670 Metal recovery device
11/10/2010EP2248832A1 A g-csf conjugate modified by water-soluble polymer
11/10/2010EP1487483B1 Chimeric infectious dna clones of porcine circovirus and uses thereof
11/10/2010CN1775946B Enhanced virus-mediated DNA transfer
11/10/2010CN101880326A Interferon-beta composite
11/09/2010US7829679 Mucin-type glycoprotein and use thereof
11/09/2010US7829678 Bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), diagnostics, vaccines; kits
11/09/2010US7829673 comprises a heavy chain variable region comprising the amino acid sequence set forth in SEQ ID NO:7 or encoded by the nucleotide sequence set forth in SEQ ID NO:6; inhibiting growth and/or proliferation of a cell expressing CD38; kits
11/09/2010US7829671 human endonuclease protein, MED1 (methyl-CpG binding endonuclease 1); drug screening; genetic or cancer screening assays
11/09/2010US7829297 selecting therapy for a human subject having a solid epithelial tumor that overexpresses ErbB2 comprising determining whether the tumor expresses p95ErbB2; reversible dual tyrosine kinase inhibitor of both ErbB2 and epidermal growth factor receptor
11/09/2010US7829064 antigen binding molecules conjugated to lipids, polymer carriers, micelles, nanoparticles or mixtures and effectors, used for therapy of diagnosis
11/09/2010CA2161684C Bioactive and/or targeted dendrimer conjugates
11/04/2010WO2010126115A1 Method for screening monoclonal antibody recognizing three-dimensional structure of membrane protein
11/04/2010US20100280228 Purification of immunoconjugates
11/04/2010US20100276373 Thimerosal Removal Device
11/03/2010EP2245040A2 Transcriptional control in alicyclobacillus acidocaldarius and associated genes, proteins, and methods
11/02/2010US7825070 Method of two-dimensionally arraying ferritin on substrate
10/2010
10/28/2010WO2010121559A1 Novel exendin variant and conjugate thereof
10/28/2010WO2010121352A1 Use of (hexenoyl trans-3)hgrf(l-44)nh2 and simvastatin in combination therapy
10/28/2010WO2010121351A1 Use of (hexenoyl trans-3)hgrf(1-44)nh2 and ritonavir in combination therapy
10/28/2010US20100273216 Methods for protein refolding
10/27/2010EP2073850B1 Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents
10/27/2010EP1218509B9 Fibroblast growth factor-like polypeptides
10/27/2010CN101870732A Method for synthesizing mono pegylation-thymopentin by solid phase and liquid phase combination
10/27/2010CN101870728A Novel Exendin variant and conjugate thereof
10/26/2010US7820792 isoform of the alpha 2 delta -4 subunit of a voltage gated calcium channel; useful to identify modulators of the channel subunit; for cancer and inflammation
10/26/2010US7820790 Low density lipoprotein receptor fusion for use in prevention and treatment of inflammation and autoimmune diseases
10/26/2010CA2249409C Iga1 protease fragment as carrier peptide
10/21/2010WO2010118985A1 Affinity material
10/21/2010US20100267627 Support for protein transfer, protein transfer agent using the support, protein transfer method, cell having protein transferred thereinto and method of producing the same
10/21/2010US20100267139 Osteopontin nanoparticle system for drug delivery
10/21/2010US20100267108 Emulsion-derived particles
10/21/2010CA2758438A1 Affinity material
10/20/2010CN101868726A Abnormal prion protein binder, and method for detection of abnormal prion protein
10/19/2010US7816151 Nanoporous membrane reactor for miniaturized reactions and enhanced reaction kinetics
10/19/2010US7816093 using nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners; used as additives and/or removed from foods, beverages and medicinals in order to modify (block) T2R-associated bitter taste
10/19/2010US7815893 formed via reductive amination with O-[2-(2-aminooxy-ethoxy)-ethyl]-hydroxyl amine; conjugated to erythropoietin
10/14/2010WO2010115835A2 Stabilizing composition for immobilized biomolecules
10/14/2010US20100261273 Mammalian Receptor Proteins; Related Reagents and Methods
10/13/2010CN1864068B Methods for reducing complexity of a sample using small epitope antibodies
10/13/2010CN101857638A Method for preparing bovine hemoglobin/titanium-based titanium dioxide hybrid material
10/13/2010CN101240031B Conjugate constructed from normal heptadecyl and RGD peptide, and its preparation method and application
10/12/2010US7812129 Unique novel Bacillus thuringiensis gene with lepidopteran activity
10/12/2010US7811580 Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopes
10/12/2010US7811570 ablating a targeted non-malignant B cell, comprising administering to a human subject having an immune disease an unconjugated monoclonal antibody (LL2 antibody) which binds to a marker that is specific for a B cell
10/12/2010CA2383955C Extracorporeal endotoxin removal method
10/12/2010CA2300176C Latent reactive polymers with biologically active moieties
10/07/2010WO2010114031A1 Method for detecting substance in biological sample
10/07/2010US20100255558 Supramolecular bioconjugates
10/07/2010CA2756109A1 Method for detecting substance in biological sample
10/06/2010EP2237035A2 Taxol derivatives for taxol immunoassay
10/06/2010EP2236521A1 Y-type polyethylene glycol modified g-csf and preparation method and use thereof
10/06/2010EP2236520A1 Stabilizing composition for immobilized biomolecules
10/06/2010EP1551449B1 Reagents and methods for engaging unique clonotypic lymphocyte receptors
10/06/2010CN101855245A PP1 ligands
10/06/2010CN101855237A Peptide ligand directed drug delivery
10/05/2010US7807862 Transgenic bovine comprising human growth hormone in its serum and methods of making
10/05/2010US7807824 in which reducing terminal unit is transformed into aldehyde group, hydroxylation; drug delivery
10/05/2010US7807387 Biological agent that causes IL-6 receptor release
10/05/2010US7807352 Using microarray comprising immobolized biopolymers which utilizes universal detection elements as tool for identifying preferential compounds
09/2010
09/30/2010WO2010109284A1 Antimicrobial cationic lipo-beta-peptides
09/30/2010US20100249020 Fast-acting insulin formulation
09/30/2010US20100248360 Nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners
09/30/2010US20100247522 Linked purine pterin hppk inhibitors useful as antibacterial agents
09/30/2010US20100242358 Hypersensitive response induced resistance in plants by seed treatment
09/29/2010EP2233504A1 An erythropoietin mimetic peptide derivatives and its pharmaceutical salt, the preparation and uses thereof
09/28/2010US7803909 Truncated tyrosine kinase for use in identifying modulators for prevention and treatment of cell proliferative disorders
09/28/2010US7803907 Polypeptides comprising monomer domains that bind to c-MET; polynucleotide encoding the polypeptide; cancer
09/28/2010US7803777 conjugates of polyoxyethylene glycol with diverse therapeutic agents, e.g., peptides, lipids, glycolipids and small molecules; utility in biotechnology and medicine
09/23/2010US20100239532 Interferon alpha2a modified by polyethylene glycol, the preparation and use thereof
09/22/2010EP2229411A1 High-density lipoprotein-like peptide-phospholipid scaffold ("hpps") nanoparticles
09/21/2010US7799902 Receptor coupling agents and compositions thereof
09/21/2010US7799898 Human transferase family members and uses thereof
09/21/2010US7799548 the wafer has a combination of a biomolecule capture-resin and an ion-exchange resin forming a charged capture resin within the wafer; contacting wafer with a stripping fluid at a temperature and for a time sufficient to strip
09/21/2010CA2352082C Carriers for combinatorial compound libraries
09/21/2010CA2307142C N-terminally chemically modified protein compositions and methods
09/16/2010US20100234279 Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
09/16/2010US20100233743 Bisubstrate fluorescent probe binding to protein kinases
09/16/2010US20100233190 Targeted polymeric prodrugs containing multifunctional linkers
09/16/2010US20100233169 Methods for treating obesity using fibroblast growth factor-Like polypeptides
09/15/2010EP2228385A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
09/15/2010EP2228384A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
09/15/2010EP1250055B1 Immune modulation with death receptor-induced apoptosis
09/14/2010US7795386 selectively inhibit alpha v beta 3 integrin; used in the treatment of diseases associated with angiogenesis and cancer
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 107